Last 12 months
Inside the activity.
0 purchase rows · 4 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 2 |
| Dec 2025 | 0 | 1 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 1 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 01, 2017 Filed Jun 2, 2017 20:40 UTC |
FERNANDEZ MICHAELDirector
|
GrantCommon Stock | 2,292 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-037303 · doc4.xml · nonDerivative · entry 1 FERNANDEZ MICHAEL · CIK 0001218838 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 94,239 F1 · shares: Restricted shares granted pursuant to Issuer's Amended and Restated 2008 Incentive Compensation Plan, as amended, in connection with annual equity award. Shares will vest in three equal installments on June 1, 2018, June 1, 2019 and June 1, 2020. Read SEC document |
| June 01, 2017 Filed Jun 2, 2017 20:39 UTC |
Clark David A.Pres. Mednax Natl Med Group
|
SaleCommon Stock | 10,202 | $54.99 | $561,040.63 |
DisclosureSEC source: 0001209191-17-037298 · doc4.xml · nonDerivative · entry 2 Clark David A. · CIK 0001443082 · Pres. Mednax Natl Med Group 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,100 F2 · kind: Sales made pursuant to Reporting Person's 10b5-1 trading plan. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in fifty-three (53) separate transactions with prices ranging from $54.16 to $55.39 for an average weighted sales price of $54.9932. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| June 01, 2017 Filed Jun 2, 2017 20:39 UTC |
Clark David A.Pres. Mednax Natl Med Group
|
GrantCommon Stock | 15,277 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-037298 · doc4.xml · nonDerivative · entry 1 Clark David A. · CIK 0001443082 · Pres. Mednax Natl Med Group 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,302 F1 · shares: Restricted shares granted pursuant to Issuer's Amended and Restated 2008 Incentive Compensation Plan, as amended, in connection with annual equity award. The vesting of the restricted shares is subject to performance based criteria but will not vest any earlier than in three equal installments on June 1, 2018, June 1, 2019 and June 1, 2020. Read SEC document |
| June 01, 2017 Filed Jun 2, 2017 20:39 UTC |
WALDEMAR, MD CARLO ADirector
|
GrantCommon Stock | 2,292 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-037292 · doc4.xml · nonDerivative · entry 1 WALDEMAR, MD CARLO A · CIK 0001218839 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,547 F1 · shares: Restricted shares granted pursuant to Issuer's Amended and Restated 2008 Incentive Compensation Plan, as amended, in connection with annual equity award. Shares will vest in three equal installments on June 1, 2018, June 1, 2019 and June 1, 2020. Read SEC document |
| June 01, 2017 Filed Jun 2, 2017 20:37 UTC |
Barker Karey DDirector
|
GrantCommon Stock | 2,292 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-037282 · doc4.xml · nonDerivative · entry 1 Barker Karey D · CIK 0001641573 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,012 F1 · shares: Restricted shares granted pursuant to Issuer's Amended and Restated 2008 Incentive Compensation Plan, as amended, in connection with annual equity award. Shares will vest in three equal installments on June 1, 2018, June 1, 2019 and June 1, 2020. Read SEC document |
| June 01, 2017 Filed Jun 2, 2017 20:37 UTC |
CALABRO JOSEPH MPresident and COO
|
SaleCommon Stock | 23,327 | $55.00 | $1,282,933.68 |
DisclosureSEC source: 0001209191-17-037286 · doc4.xml · nonDerivative · entry 2 CALABRO JOSEPH M · CIK 0001218834 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 262,784 F2 · kind: Sales made pursuant to Reporting Person's 10b5-1 trading plan. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in sixty-four (64) separate transactions with prices ranging from $54.13 to $55.40 for an average weighted sales price of $54.9978. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F4 · balance_after: Reflects a reduction of 10,268 in previously reported target restricted shares that were granted pursuant to the Issuer's Amended and Restated 2008 Incentive Compensation Plan, as amended, in connection with achievement of specified performance-based criteria below target for the performance period from April 1, 2016 through March 31, 2017. The decrease in restricted shares impacts the installments vesting on June 1, 2017, June 1, 2018 and June 1, 2019. The vesting of such shares remains subject to continued employment. Read SEC document |
| June 01, 2017 Filed Jun 2, 2017 20:37 UTC |
CALABRO JOSEPH MPresident and COO
|
GrantCommon Stock | 67,398 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-037286 · doc4.xml · nonDerivative · entry 1 CALABRO JOSEPH M · CIK 0001218834 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 296,379 F1 · shares: Restricted shares granted pursuant to the Issuer's Amended and Restated 2008 Incentive Compensation Plan, as amended, in connection with annual equity award. The number of shares being reported represents the "target" number of restricted shares and does not include the right of the reporting person to receive up to 16,849 additional shares based on the achievement of certain performance-based criteria for the period from April 1, 2017 through March 31, 2018. The actual number of shares earned could be less than or greater than the target number, depending on the level of performance achieved, and all of the restricted shares granted are subject to forfeiture if minimum levels of performance are not met. Any restricted shares earned will not vest any earlier than in three equal installments on June 1, 2018, June 1, 2019 and June 1, 2020. Read SEC document |
| June 01, 2017 Filed Jun 2, 2017 20:36 UTC |
Andreano Dominic JSVP, General Counsel and Secy
|
GrantCommon Stock | 8,987 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-037278 · doc4.xml · nonDerivative · entry 1 Andreano Dominic J · CIK 0001549694 · SVP, General Counsel and Secy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,216.22 F1 · shares: Restricted shares granted pursuant to Issuer's Amended and Restated 2008 Incentive Compensation Plan, as amended, in connection with annual equity award. The vesting of the restricted shares is subject to performance based criteria but will not vest any earlier than in three equal installments on June 1, 2018, June 1, 2019 and June 1, 2020. Read SEC document |
| June 01, 2017 Filed Jun 2, 2017 20:36 UTC |
ALVAREZ CESAR LDirector
|
GrantCommon Stock | 2,292 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-037277 · doc4.xml · nonDerivative · entry 1 ALVAREZ CESAR L · CIK 0001220297 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,547 F1 · shares: Restricted shares granted pursuant to Issuer's Amended and Restated 2008 Incentive Compensation Plan, as amended, in connection with annual equity award. Shares will vest in three equal installments on June 1, 2018, June 1, 2019 and June 1, 2020. Read SEC document |
| May 05, 2017 Filed May 8, 2017 20:29 UTC |
Lopez-Blanco VivianChief Financial Officer
|
SaleCommon Stock | 7,778 | $55.82 | $434,182.74 |
DisclosureSEC source: 0001209191-17-030602 · doc4.xml · nonDerivative · entry 1 Lopez-Blanco Vivian · CIK 0001479017 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,319.24 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in ten (10) separate transactions with prices ranging from $55.80 to $55.89 for an average weighted sales price of $55.8219. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 05, 2017 Filed May 8, 2017 20:28 UTC |
Kadre ManuelDirector
|
PurchaseCommon Stock | 21,704 | $55.79 | $1,210,837.94 |
DisclosureSEC source: 0001209191-17-030600 · doc4.xml · nonDerivative · entry 1 Kadre Manuel · CIK 0001396538 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 111,255 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in seventy-four (74) separate transactions with prices ranging from $55.69 to $55.94 for an average weighted purchase price of $55.7887. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Read SEC document |
| March 15, 2017 Filed Mar 17, 2017 20:23 UTC |
Andreano Dominic JSVP, General Counsel and Secy
|
SaleCommon Stock | 6,517 | $70.84 | $461,645.38 |
DisclosureSEC source: 0001209191-17-021381 · doc4.xml · nonDerivative · entry 1 Andreano Dominic J · CIK 0001549694 · SVP, General Counsel and Secy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,229.22 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in twenty-four (24) separate transactions with prices ranging from $70.69 to $70.96 for an average weighted sales price of $70.8371. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 23, 2017 Filed Feb 24, 2017 21:31 UTC |
SOSA ENRIQUEDirector
|
Exercise / conversionStock Options (Right to Buy) · Derivative | 10,668 | $32.33 Strike: $32.33 | $344,843.10 |
DisclosureSEC source: 0001209191-17-014340 · doc4.xml · derivative · entry 3 SOSA ENRIQUE · CIK 0001219818 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,668 shares Expires 2017-11-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 23, 2017 Filed Feb 24, 2017 21:31 UTC |
SOSA ENRIQUEDirector
|
SaleCommon Stock | 10,668 | $69.65 | $743,060.34 |
DisclosureSEC source: 0001209191-17-014340 · doc4.xml · nonDerivative · entry 2 SOSA ENRIQUE · CIK 0001219818 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,255 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in twenty-six (26) separate transactions with prices ranging from $69.49 to $69.74 for an average weighted sales price of $69.6532. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 23, 2017 Filed Feb 24, 2017 21:31 UTC |
SOSA ENRIQUEDirector
|
Exercise / conversionCommon Stock | 10,668 | $32.33 | $344,843.10 |
DisclosureSEC source: 0001209191-17-014340 · doc4.xml · nonDerivative · entry 1 SOSA ENRIQUE · CIK 0001219818 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,923 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 17, 2017 Filed Feb 17, 2017 21:36 UTC |
Lopez-Blanco VivianChief Financial Officer
|
SaleCommon Stock | 15,164 | $70.01 | $1,061,605.86 |
DisclosureSEC source: 0001209191-17-012145 · doc4.xml · nonDerivative · entry 1 Lopez-Blanco Vivian · CIK 0001479017 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,097.24 F1 · price: The price reported in Column 4 is an weighted average price. These shares were sold in seven separate transactions with prices ranging from $70.00 to $70.03 for an average weighted sales price of $70.0083. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 16, 2017 Filed Feb 17, 2017 21:31 UTC |
Pepia John CPrincipal Accounting Officer
|
Exercise / conversionStock Options (Right to Buy) · Derivative | 2,500 | $28.55 Strike: $28.55 | $71,362.50 |
DisclosureSEC source: 0001209191-17-012120 · doc4.xml · derivative · entry 4 Pepia John C · CIK 0001674717 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,500 shares Expires 2017-06-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 16, 2017 Filed Feb 17, 2017 21:31 UTC |
Pepia John CPrincipal Accounting Officer
|
SaleCommon Stock | 1,500 | $69.58 | $104,371.50 |
DisclosureSEC source: 0001209191-17-012120 · doc4.xml · nonDerivative · entry 3 Pepia John C · CIK 0001674717 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,525 F1 · balance_after: Includes 9,143 shares that were acquired by Reporting Person through Issuer's Employee Stock Purchase Plan. Read SEC document |
| February 16, 2017 Filed Feb 17, 2017 21:31 UTC |
Pepia John CPrincipal Accounting Officer
|
SaleCommon Stock | 1,000 | $69.58 | $69,581.20 |
DisclosureSEC source: 0001209191-17-012120 · doc4.xml · nonDerivative · entry 2 Pepia John C · CIK 0001674717 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,025 Read SEC document |
| February 16, 2017 Filed Feb 17, 2017 21:31 UTC |
Pepia John CPrincipal Accounting Officer
|
Exercise / conversionCommon Stock | 2,500 | $28.55 | $71,362.50 |
DisclosureSEC source: 0001209191-17-012120 · doc4.xml · nonDerivative · entry 1 Pepia John C · CIK 0001674717 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,025 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 16, 2017 Filed Feb 17, 2017 21:31 UTC |
GABOS PAUL GDirector
|
Exercise / conversionStock Options (Right to Buy) · Derivative | 10,668 | $27.72 Strike: $27.72 | $295,663.62 |
DisclosureSEC source: 0001209191-17-012117 · doc4.xml · derivative · entry 5 GABOS PAUL G · CIK 0001216803 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,668 shares Expires 2018-05-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 16, 2017 Filed Feb 17, 2017 21:31 UTC |
GABOS PAUL GDirector
|
Exercise / conversionStock Options (Right to Buy) · Derivative | 10,668 | $32.33 Strike: $32.33 | $344,843.10 |
DisclosureSEC source: 0001209191-17-012117 · doc4.xml · derivative · entry 4 GABOS PAUL G · CIK 0001216803 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,668 shares Expires 2017-11-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 16, 2017 Filed Feb 17, 2017 21:31 UTC |
GABOS PAUL GDirector
|
SaleCommon Stock | 21,336 | $69.63 | $1,485,664.08 |
DisclosureSEC source: 0001209191-17-012117 · doc4.xml · nonDerivative · entry 3 GABOS PAUL G · CIK 0001216803 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,255 F1 · price: The price reported in Column 4 is an weighted average price. These shares were sold in thirty-three (33) separate transactions with prices ranging from $69.4250 to $69.78 for an average weighted sales price of $69.6318. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 16, 2017 Filed Feb 17, 2017 21:31 UTC |
GABOS PAUL GDirector
|
Exercise / conversionCommon Stock | 10,668 | $27.72 | $295,663.62 |
DisclosureSEC source: 0001209191-17-012117 · doc4.xml · nonDerivative · entry 2 GABOS PAUL G · CIK 0001216803 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,591 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 16, 2017 Filed Feb 17, 2017 21:31 UTC |
GABOS PAUL GDirector
|
Exercise / conversionCommon Stock | 10,668 | $32.33 | $344,843.10 |
DisclosureSEC source: 0001209191-17-012117 · doc4.xml · nonDerivative · entry 1 GABOS PAUL G · CIK 0001216803 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,923 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 16, 2017 Filed Feb 17, 2017 21:30 UTC |
Andreano Dominic JSVP, General Counsel and Secy
|
Exercise / conversionStock Options (Right to Buy) · Derivative | 6,000 | $28.55 Strike: $28.55 | $171,270.00 |
DisclosureSEC source: 0001209191-17-012112 · doc4.xml · derivative · entry 3 Andreano Dominic J · CIK 0001549694 · SVP, General Counsel and Secy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,000 shares Expires 2017-06-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 16, 2017 Filed Feb 17, 2017 21:30 UTC |
Andreano Dominic JSVP, General Counsel and Secy
|
SaleCommon Stock | 6,000 | $69.59 | $417,531.00 |
DisclosureSEC source: 0001209191-17-012112 · doc4.xml · nonDerivative · entry 2 Andreano Dominic J · CIK 0001549694 · SVP, General Counsel and Secy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,746.22 F1 · price: The price reported in Column 4 is a weighted average sales price. These shares were sold in twenty (20) separate transactions with prices ranging from $69.50 to $69.72 for a weighted average sales price of $69.5885. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 16, 2017 Filed Feb 17, 2017 21:30 UTC |
Andreano Dominic JSVP, General Counsel and Secy
|
Exercise / conversionCommon Stock | 6,000 | $28.55 | $171,270.00 |
DisclosureSEC source: 0001209191-17-012112 · doc4.xml · nonDerivative · entry 1 Andreano Dominic J · CIK 0001549694 · SVP, General Counsel and Secy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,746.22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 13, 2017 Filed Jun 2, 2017 20:43 UTC |
MEDEL ROGER MDDirector · Chief Executive Officer
|
GiftCommon Stock | 16,020 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-037322 · doc4.xml · nonDerivative · entry 1 MEDEL ROGER MD · CIK 0001093125 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,233,304 F1 · shares: Disposition pursuant to a gift to a charitable institute. Read SEC document |
| February 10, 2017 Filed Feb 13, 2017 21:50 UTC |
Goldschmidt, MD Pascal JDirector
|
Exercise / conversionStock Options (Right to Buy) · Derivative | 8,280 | $36.25 Strike: $36.25 | $300,150.00 |
DisclosureSEC source: 0001209191-17-010046 · doc4.xml · derivative · entry 9 Goldschmidt, MD Pascal J · CIK 0001356123 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 8,280 shares Expires 2021-05-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 10, 2017 Filed Feb 13, 2017 21:50 UTC |
Goldschmidt, MD Pascal JDirector
|
Exercise / conversionStock Options (Right to Buy) · Derivative | 9,922 | $29.36 Strike: $29.36 | $291,260.31 |
DisclosureSEC source: 0001209191-17-010046 · doc4.xml · derivative · entry 8 Goldschmidt, MD Pascal J · CIK 0001356123 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 9,922 shares Expires 2020-05-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 10, 2017 Filed Feb 13, 2017 21:50 UTC |
Goldschmidt, MD Pascal JDirector
|
Exercise / conversionStock Options (Right to Buy) · Derivative | 10,668 | $27.72 Strike: $27.72 | $295,663.62 |
DisclosureSEC source: 0001209191-17-010046 · doc4.xml · derivative · entry 7 Goldschmidt, MD Pascal J · CIK 0001356123 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,668 shares Expires 2018-05-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 10, 2017 Filed Feb 13, 2017 21:50 UTC |
Goldschmidt, MD Pascal JDirector
|
Exercise / conversionStock Options (Right to Buy) · Derivative | 818 | $32.33 Strike: $32.33 | $26,441.85 |
DisclosureSEC source: 0001209191-17-010046 · doc4.xml · derivative · entry 6 Goldschmidt, MD Pascal J · CIK 0001356123 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 818 shares Expires 2017-11-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 10, 2017 Filed Feb 13, 2017 21:50 UTC |
Goldschmidt, MD Pascal JDirector
|
SaleCommon Stock | 25,294 | $67.82 | $1,715,317.67 |
DisclosureSEC source: 0001209191-17-010046 · doc4.xml · nonDerivative · entry 5 Goldschmidt, MD Pascal J · CIK 0001356123 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,749 F1 · price: Sales of shares were made in thirty-three (33) separate transactions with prices ranging from $67.70 to $68.05 for an average weighted sales price of $67.8152. Read SEC document |
| February 10, 2017 Filed Feb 13, 2017 21:50 UTC |
Goldschmidt, MD Pascal JDirector
|
Exercise / conversionCommon Stock | 8,280 | $36.25 | $300,150.00 |
DisclosureSEC source: 0001209191-17-010046 · doc4.xml · nonDerivative · entry 4 Goldschmidt, MD Pascal J · CIK 0001356123 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,043 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 10, 2017 Filed Feb 13, 2017 21:50 UTC |
Goldschmidt, MD Pascal JDirector
|
Exercise / conversionCommon Stock | 9,922 | $29.36 | $291,260.31 |
DisclosureSEC source: 0001209191-17-010046 · doc4.xml · nonDerivative · entry 3 Goldschmidt, MD Pascal J · CIK 0001356123 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,763 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 10, 2017 Filed Feb 13, 2017 21:50 UTC |
Goldschmidt, MD Pascal JDirector
|
Exercise / conversionCommon Stock | 10,668 | $27.72 | $295,663.62 |
DisclosureSEC source: 0001209191-17-010046 · doc4.xml · nonDerivative · entry 2 Goldschmidt, MD Pascal J · CIK 0001356123 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,841 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 10, 2017 Filed Feb 13, 2017 21:50 UTC |
Goldschmidt, MD Pascal JDirector
|
Exercise / conversionCommon Stock | 818 | $32.33 | $26,441.85 |
DisclosureSEC source: 0001209191-17-010046 · doc4.xml · nonDerivative · entry 1 Goldschmidt, MD Pascal J · CIK 0001356123 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,173 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 10, 2017 Filed Feb 15, 2017 22:04 UTC Amendment |
Goldschmidt, MD Pascal JDirector
|
OtherCommon Stock | 25,294 | $67.82 | $1,715,317.67 |
DisclosureSEC source: 0001209191-17-011142 · doc4a.xml · nonDerivative · entry 1 Goldschmidt, MD Pascal J · CIK 0001356123 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,749 F1 · kind: Disposition of shares of Common Stock of the Issuer pursuant to a domestic relations order. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in thirty-three (33) separate transactions with prices ranging from $67.70 to $68.05 for an average weighted sales price of $67.8152. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 09, 2017 Filed Feb 10, 2017 21:56 UTC |
WALDEMAR, MD CARLO ADirector
|
Exercise / conversionStock Options (Right to Buy) · Derivative | 5,334 | $32.33 Strike: $32.33 | $172,421.55 |
DisclosureSEC source: 0001209191-17-009613 · doc4.xml · derivative · entry 3 WALDEMAR, MD CARLO A · CIK 0001218839 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,334 shares Expires 2017-11-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 09, 2017 Filed Feb 10, 2017 21:56 UTC |
WALDEMAR, MD CARLO ADirector
|
SaleCommon Stock | 5,334 | $67.90 | $362,186.07 |
DisclosureSEC source: 0001209191-17-009613 · doc4.xml · nonDerivative · entry 2 WALDEMAR, MD CARLO A · CIK 0001218839 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,255 F1 · price: Sales of shares were made in seventeen (17) separate transactions with prices ranging from $67.83 to $68.00 for a weighted average sales price of $67.9014. Read SEC document |
| February 09, 2017 Filed Feb 10, 2017 21:56 UTC |
WALDEMAR, MD CARLO ADirector
|
Exercise / conversionCommon Stock | 5,334 | $32.33 | $172,421.55 |
DisclosureSEC source: 0001209191-17-009613 · doc4.xml · nonDerivative · entry 1 WALDEMAR, MD CARLO A · CIK 0001218839 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,589 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 17, 2017 Filed Jan 17, 2017 21:41 UTC |
Lopez-Blanco VivianChief Financial Officer
|
SaleCommon Stock | 10,000 | $70.95 | $709,500.00 |
DisclosureSEC source: 0001209191-17-003876 · doc4.xml · nonDerivative · entry 1 Lopez-Blanco Vivian · CIK 0001479017 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,261.24 F1 · kind: Sales made pursuant to Reporting Person's 10b5-1 trading plan. Read SEC document |
| December 07, 2016 Filed Dec 21, 2016 22:03 UTC |
Goldschmidt, MD Pascal JDirector
|
PurchaseCommon Stock | 2,100 | $66.52 | $139,681.50 |
DisclosureSEC source: 0001209191-16-156355 · doc4.xml · nonDerivative · entry 1 Goldschmidt, MD Pascal J · CIK 0001356123 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,355 Read SEC document |
| November 10, 2016 Filed Nov 10, 2016 21:39 UTC |
Kadre ManuelDirector
|
Exercise / conversionStock Options (Right to Buy) · Derivative | 8,280 | $36.25 Strike: $36.25 | $300,150.00 |
DisclosureSEC source: 0001209191-16-149372 · doc4.xml · derivative · entry 12 Kadre Manuel · CIK 0001396538 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 8,280 shares Expires 2021-05-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 10, 2016 Filed Nov 10, 2016 21:39 UTC |
Kadre ManuelDirector
|
Exercise / conversionStock Options (Right to Buy) · Derivative | 9,922 | $29.36 Strike: $29.36 | $291,260.31 |
DisclosureSEC source: 0001209191-16-149372 · doc4.xml · derivative · entry 11 Kadre Manuel · CIK 0001396538 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 9,922 shares Expires 2020-05-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 10, 2016 Filed Nov 10, 2016 21:39 UTC |
Kadre ManuelDirector
|
Exercise / conversionStock Options (Right to Buy) · Derivative | 17,584 | $18.91 Strike: $18.91 | $332,513.44 |
DisclosureSEC source: 0001209191-16-149372 · doc4.xml · derivative · entry 10 Kadre Manuel · CIK 0001396538 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 17,584 shares Expires 2019-05-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 10, 2016 Filed Nov 10, 2016 21:39 UTC |
Kadre ManuelDirector
|
Exercise / conversionStock Options (Right to Buy) · Derivative | 10,668 | $27.72 Strike: $27.72 | $295,663.62 |
DisclosureSEC source: 0001209191-16-149372 · doc4.xml · derivative · entry 9 Kadre Manuel · CIK 0001396538 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,668 shares Expires 2018-05-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 10, 2016 Filed Nov 10, 2016 21:39 UTC |
Kadre ManuelDirector
|
Exercise / conversionStock Options (Right to Buy) · Derivative | 5,174 | $32.33 Strike: $32.33 | $167,249.55 |
DisclosureSEC source: 0001209191-16-149372 · doc4.xml · derivative · entry 8 Kadre Manuel · CIK 0001396538 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,174 shares Expires 2017-11-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 10, 2016 Filed Nov 10, 2016 21:39 UTC |
Kadre ManuelDirector
|
Exercise / conversionStock Options (Right to Buy) · Derivative | 26,668 | $29.40 Strike: $29.40 | $784,039.20 |
DisclosureSEC source: 0001209191-16-149372 · doc4.xml · derivative · entry 7 Kadre Manuel · CIK 0001396538 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 26,668 shares Expires 2017-05-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.